This Fund is Soft Closed and is not currently available to new investors

Biotechnology Fund

Equity investors in medical innovation

Launch Date31.10.2013
Base CurrencyUS$
DenominationsUS$ / GBP / EUR
DomicileDublin, Ireland
IndexNASDAQ Biotechnology
US$37.01
US$ Class I Dist
NAV per share 03.12.2020
£778.3mAUM

AUM 30.10.2020

Holdings
68.45% Active Share
As at 30.10.2020